Seite - 89 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Conniotet al. Nanocarriers for immunecell targetingand tracking Helmy, K. Y., Patel, S. A., Nahas, G. R., and Rameshwar, P. (2013). Cancer immunotherapy: accomplishments to date and future promise.Ther. Deliv. 4, 1307–1320.doi:10.4155/tde.13.88 Henderson,R.A.,Mossman,S.,Nairn,N., andCheever,M.A. (2005).Cancervac- cinesandimmunotherapies:emergingperspectives.Vaccine23,2359–2362.doi: 10.1016/j.vaccine.2005.01.082 Herwig,M.C.,Bergstrom,C.,Wells,J.R.,Holler,T.,andGrossniklaus,H.E.(2013). M2/M1ratiooftumorassociatedmacrophagesandPPAR-gammaexpressionin uvealmelanomaswith class 1 andclass 2molecularprofiles.Exp.EyeRes.107, 52–58.doi:10.1016/j.exer.2012.11.012 Higgins, J. P., Bernstein, M. B., and Hodge, J. W. (2009). Enhancing immune responses to tumor-associated antigens.Cancer Biol. Ther. 8, 1440–1449. doi: 10.4161/cbt.8.15.9133 Hildner,K.,Edelson,B.T.,Purtha,W.E.,Diamond,M.,Matsushita,H.,Kohyama, M.,etal. (2008).Batf3deficiencyrevealsacriticalroleforCD8alpha+dendritic cells in cytotoxic T cell immunity. Science 322, 1097–1100. doi: 10.1126/sci- ence.1164206 Hillaireau,H., andCouvreur,P. (2009).Nanocarriers’ entry into thecell: relevance to drug delivery.Cell. Mol. Life Sci. 66, 2873–2896. doi: 10.1007/s00018-009- 0053-z Hinrichs,C. S.,Borman,Z.A.,Gattinoni, L.,Yu,Z.,Burns,W.R.,Huang, J., et al. (2011). Human effector CD8+T cells derived fromnaive rather thanmem- ory subsets possess superior traits for adoptive immunotherapy. Blood 117, 808–814.doi:10.1182/blood-2010-05-286286 Hong, H., Yang, K., Zhang, Y., Engle, J. W., Feng, L., Yang, Y., et al. (2012). In vivo targeting and imaging of tumor vasculaturewith radiolabeled, antibody- conjugatednanographene.ACSNano6,2361–2370.doi:10.1021/nn204625e Hughes,M.S.,Marsh,J.N.,Zhang,H.,Woodson,A.K.,Allen,J.S.,Lacy,E.K.,etal. (2006). Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo. IEEETrans. Ultrason. Ferroelectr. Freq.Control53,1609–1616.doi:10.1109/TUFFC.2006.1678189 Hurwitz,A.A., Foster, B.A.,Kwon, E.D., Truong,T.,Choi, E.M.,Greenberg,N. M., etal. (2000).Combination immunotherapyofprimaryprostatecancer ina transgenicmousemodelusingCTLA-4blockade.CancerRes.60,2444–2448. Huwyler, J.,Drewe, J.,andKrahenbuhl,S. (2008).Tumortargetingusingliposomal antineoplasticdrugs. Int. J.Nanomedicine3,21–29.doi:10.2147/IJN.S1253 Ino, Y., Yamazaki-Itoh, R., Shimada, K., Iwasaki,M., Kosuge, T., Kanai, Y., et al. (2013). Immunecell infiltration as an indicatorof the immunemicroenviron- mentofpancreaticcancer.Br. J.Cancer108,914–923.doi:10.1038/bjc.2013.32 Ivkov, R., Denardo, S. J., Daum,W., Foreman, A. R., Goldstein, R. C., Nemkov, V. S., et al. (2005). Application of high amplitude alternatingmagnetic fields for heat induction of nanoparticles localized in cancer.Clin. Cancer Res. 11, 7093s–7103s.doi:10.1158/1078-0432.CCR-1004-0016 Iyer, A. K., Khaled, G., Fang, J., andMaeda,H. (2006). Exploiting the enhanced permeability and retention effect for tumor targeting.DrugDiscov. Today 11, 812–818.doi:10.1016/j.drudis.2006.07.005 Jain, T. K., Foy, S. P., Erokwu, B., Dimitrijevic, S., Flask, C. A., and Labhasetwar, V. (2009).Magnetic resonance imaging ofmultifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearingmice.Biomaterials 30, 6748–6756. doi:10.1016/j.biomaterials.2009.08.042 Jang, B., Park, S., Kang, S. H., Kim, J. K., Kim, S. K., Kim, I. H., et al. (2012). Gold nanorods for target selective SPECT/CT imaging and photothermal therapy in vivo.Quant. ImagingMed. Surg. 2, 1–11. doi: 10.3978/.issn.2223- 4292.2012.01.03 Janjic, J.M.,andAhrens,E.T.(2009).Fluorine-containingnanoemulsionsforMRI cell tracking.Wiley Interdiscip.Rev.Nanomed.Nanobiotechnol.1,492–501.doi: 10.1002/wnan.35 Jarrett, B. R., Gustafsson, B., Kukis, D. L., and Louie, A. Y. (2008). Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging. Bioconjug. Chem.19,1496–1504.doi:10.1021/bc800108v Jhaveri, A. M., and Torchilin, V. P. (2014). Multifunctional polymeric micelles for delivery of drugs and siRNA. Front. Pharmacol. 5:77. doi: 10.3389/fphar.2014.00077 Johansen, P., Estevez, F., Zurbriggen, R., Merkle, H. P., Gluck, R., Corradin, G., et al. (2000).Towardsclinical testingofa single-administration tetanusvaccine basedonPLA/PLGAmicrospheres.Vaccine19,1047–1054.doi:10.1016/S0264- 410X(00)00343-1 Joshi, P. P., Yoon, S. J., Chen, Y. S., Emelianov, S., and Sokolov, K. V. (2013). Development and optimization of near-IR contrast agents for immune cell tracking. Biomed. Opt. Express 4, 2609–2618. doi: 10.1364/BOE.4. 002609 Kaida, S., Cabral, H., Kumagai,M., Kishimura, A., Terada, Y., Sekino,M., et al. (2010). Visible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumormodel. Cancer Res.70,7031–7041.doi:10.1158/0008-5472.CAN-10-0303 Kazzaz, J., Singh,M.,Ugozzoli,M., Chesko, J., Soenawan, E., andO’Hagan,D.T. (2006). Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency. J. Control. Release 110, 566–573. doi: 10.1016/j.jconrel.2005.10.010 Keller, S.,Wilson, J. T., Patilea, G. I., Kern,H. B., Convertine, A. J., and Stayton, P. S. (2014).Neutral polymermicelle carrierswith pH-responsive, endosome- releasingactivitymodulateantigentraffickingtoenhanceCD8Tcell responses. J.Control.Release191,24–33.doi:10.1016/j.jconrel.2014.03.041 Kenny,G.D.,Kamaly,N.,Kalber,T.L.,Brody,L.P., Sahuri,M.,Shamsaei,E., et al. (2011). Novelmultifunctional nanoparticlemediates siRNA tumour delivery, visualisationand therapeutic tumour reduction in vivo. J.Control.Release149, 111–116.doi:10.1016/j.jconrel.2010.09.020 Khan, D. R., Rezler, E. M., Lauer-Fields, J., and Fields, G. B. (2008). Effects of drughydrophobicityon liposomal stability.Chem.Biol.DrugDes.71,3–7.doi: 10.1111/j.1747-0285.2007.00610.x Kikkeri, R., Lepenies, B., Adibekian, A., Laurino, P., and Seeberger, P.H. (2009). Invitro imagingand in vivo liver targetingwithcarbohydrate cappedquantum dots. J.Am.Chem.Soc.131,2110–2112.doi:10.1021/ja807711w Kim,J.,Kim,H.S.,Lee,N.,Kim,T.,Kim,H.,Yu,T., etal. (2008a).Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. Int. Ed Engl. 47, 8438–8441. doi: 10.1002/anie.200802469 Kim,J.,Lee, J.E.,Lee,S.H.,Yu,J.H.,Lee, J.H.,Park,T.G.,etal. (2008b).Designed fabricationof amultifunctionalpolymernanomedicalplatformfor simultane- ouscancer-targetedimagingandmagneticallyguideddrugdelivery.Adv.Mater. 20,478.doi:10.1002/adma.200701726 Kim, S., Lim, Y. T., Soltesz, E. G., DeGrand, A.M., Lee, J., Nakayama, A., et al. (2004).Near-infraredfluorescenttypeIIquantumdotsforsentinel lymphnode mapping.Nat.Biotechnol.22,93–97.doi:10.1038/nbt920 Kim, S.W., Zimmer, J. P., Ohnishi, S., Tracy, J. B., Frangioni, J. V., andBawendi, M. G. (2005). Engineering InAs(x)P(1-x)/InP/ZnSe III-V alloyed core/shell quantumdots for thenear-infrared. J. Am.Chem. Soc.127, 10526–10532. doi: 10.1021/ja0434331 Kim,T.H., Jin,H.,Kim,H.W.,Cho,M.H., andCho,C.S. (2006).Mannosylated chitosannanoparticle-basedcytokinegenetherapysuppressedcancergrowthin BALB/cmice bearingCT-26 carcinoma cells.Mol.Cancer Ther. 5, 1723–1732. doi:10.1158/1535-7163.MCT-05-0540 Kindt,T. J.,Goldsby,R.A.,Osborne,B.A., andKuby, J. (2006).KubyImmunology. NewYork,NY;Basingstoke:W.H.Freeman. Kircher, M. F., Allport, J. R., Graves, E. E., Love, V., Josephson, L., Lichtman, A. H., et al. (2003). In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors.Cancer Res. 63, 6838–6846. Kircher, M. F., Gambhir, S. S., and Grimm, J. (2011). Noninvasive cell-tracking methods.Nat.Rev.Clin.Oncol.8,677–688.doi:10.1038/nrclinonc.2011.141 Kirkwood, J. M., Butterfield, L. H., Tarhini, A. A., Zarour, H., Kalinski, P., and Ferrone, S. (2012). Immunotherapy of cancer in 2012.CACancer J. Clin. 62, 309–335.doi:10.3322/caac.20132 Koebel, C.M., Vermi,W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., et al. (2007). Adaptive immunity maintains occult cancer in an equilibrium state. Nature450,903–907.doi:10.1038/nature06309 Kopelman,R.,Koo,Y.E.L.,Philbert,M.,Moffat,B.A.,Reddy,G.R.,McConville,P., et al. (2005).Multifunctionalnanoparticleplatforms for in vivoMRIenhance- ment andphotodynamic therapy of a rat brain cancer. J.Magn.Magn.Mater. 293,404–410.doi:10.1016/j.jmmm.2005.02.061 Krishnamachari, Y., Geary, S. M., Lemke, C. D., and Salem, A. K. (2011). Nanoparticledelivery systems incancervaccines.Pharm.Res.28,215–236.doi: 10.1007/s11095-010-0241-4 Krug, L. M., Ragupathi, G., Hood, C., Kris, M. G., Miller, V. A., Allen, J. R., et al. (2004).Vaccinationofpatientswith small-cell lungcancerwith synthetic fucosylGM-1 conjugated to keyhole limpet hemocyanin.Clin.CancerRes.10, 6094–6100.doi:10.1158/1078-0432.CCR-04-0482 Frontiers inChemistry | ChemicalEngineering November2014 |Volume2 |Article105 | 89